全文获取类型
收费全文 | 2703篇 |
免费 | 12篇 |
专业分类
电工技术 | 21篇 |
综合类 | 1篇 |
化学工业 | 132篇 |
金属工艺 | 27篇 |
机械仪表 | 15篇 |
建筑科学 | 36篇 |
矿业工程 | 1篇 |
能源动力 | 16篇 |
轻工业 | 97篇 |
水利工程 | 14篇 |
石油天然气 | 1篇 |
无线电 | 75篇 |
一般工业技术 | 168篇 |
冶金工业 | 1979篇 |
原子能技术 | 9篇 |
自动化技术 | 123篇 |
出版年
2021年 | 5篇 |
2019年 | 7篇 |
2017年 | 7篇 |
2016年 | 8篇 |
2015年 | 5篇 |
2014年 | 8篇 |
2013年 | 107篇 |
2012年 | 19篇 |
2011年 | 36篇 |
2010年 | 24篇 |
2009年 | 29篇 |
2008年 | 25篇 |
2007年 | 37篇 |
2006年 | 25篇 |
2005年 | 37篇 |
2004年 | 26篇 |
2003年 | 29篇 |
2002年 | 27篇 |
2001年 | 24篇 |
2000年 | 21篇 |
1999年 | 65篇 |
1998年 | 591篇 |
1997年 | 327篇 |
1996年 | 242篇 |
1995年 | 119篇 |
1994年 | 135篇 |
1993年 | 113篇 |
1992年 | 32篇 |
1991年 | 37篇 |
1990年 | 34篇 |
1989年 | 30篇 |
1988年 | 39篇 |
1987年 | 29篇 |
1986年 | 34篇 |
1985年 | 42篇 |
1984年 | 10篇 |
1983年 | 14篇 |
1982年 | 18篇 |
1981年 | 17篇 |
1980年 | 24篇 |
1979年 | 5篇 |
1978年 | 13篇 |
1977年 | 46篇 |
1976年 | 112篇 |
1975年 | 12篇 |
1973年 | 5篇 |
1971年 | 6篇 |
1968年 | 4篇 |
1967年 | 4篇 |
1966年 | 5篇 |
排序方式: 共有2715条查询结果,搜索用时 31 毫秒
21.
Uterine angiomyolipomas are rare lesions composed of mature adipose tissue, smooth muscle, fibrous connective tissue, and blood vessels in varying proportions. We reported the first case of angiomyolipoma associated with a normal pregnancy. Initially, the tumor developed intramurally and could have been confused with a partial molar gestation. After delivery, tumor development was extensive and subserosal, making differential diagnosis from a sarcoma difficult. The question of histological diagnosis, as well as that of immunocytochemical analysis which seems to be helpful in such cases, is discussed here. 相似文献
22.
23.
TJ Schnitzer JR Donahue EP Toomey RM Holtby GR Scuderi PL Adams MP Poland 《Canadian Metallurgical Quarterly》1998,20(1):110-124
The known effects of commonly used nonsteroidal anti-inflammatory drugs (NSAIDs) on hemostatic parameters have led to concern over their use in the perioperative period. Nabumetone, unlike other NSAIDs, has little effect on collagen-induced platelet aggregation. To evaluate the effect of nabumetone 2000 mg daily on other hemostatic parameters (e.g., bleeding time, prothrombin time, and partial thromboplastin time) in the clinical setting, this double-masked study was conducted in patients with osteoarthritis undergoing arthroscopic knee surgery. After a 1-week placebo washout period, 58 patients were randomized to receive nabumetone and 53 were randomized to receive placebo. They were assessed before surgery (after 1 to 2 weeks of treatment) and again after surgery (after an additional 3 weeks of treatment). The study was designed to have 90% power to show equivalence in bleeding time to within 1.5 minutes, a difference assumed to be of no clinical importance. No meaningful differences were observed between the groups in any of the measured hemostatic parameters. Before surgery, the bleeding time increased by only 0.3 minutes with nabumetone and decreased by 0.2 minutes with placebo. The mean (+/- SD) difference between the groups in change from baseline was 0.5 +/- 0.3 minutes. After surgery, the changes were 0.1 minutes and 0.0 minutes, respectively, and the difference between groups was 0.2 +/- 0.3 minutes. These differences were neither statistically nor clinically significant, and maximum individual increases were similar in each group. Furthermore, there were no reports of abnormal bleeding in the operative knees. The results of this study show that nabumetone had little or no effect on hemostasis and suggest that this drug can be used safely in the perioperative period. 相似文献
24.
25.
26.
27.
28.
29.
Data from the Cancer Registry of Slovenia were used in a cohort study to determine whether the incidence of second primary cancers in patients with first primary breast cancer differs from the incidence expected in the general population. Special interest was given to long-term survivors. The expected numbers of second primary cancers were calculated by multiplying the number of appropriate person-years at risk by the corresponding age- and calendar-period-specific cancer incidence rates for women in Slovenia. The risk of a second primary cancer was expressed as the standardized incidence ratio (SIR). Of the 8,917 patients newly diagnosed in the period 1961-85 and followed-up to the end of 1994, 547 (6.2 percent) developed second primary cancers, whereas 410 (4.7 percent) were expected (SIR = 1.3, 95 percent confidence interval [CI] = 1.2-1.4). The risk was higher among younger patients. In long-term survivors, the risk was increased significantly for second primary cancer of the breast (SIR = 1.4, CI = 1.1-1.7), lung cancer (SIR = 1.6, CI = 1.1-2.3), melanoma (SIR = 2.7, CI = 1.5-4.4) and non-melanoma skin cancers(SIR = 2.0, CI = 1.6-2.4), corpus uteri cancer(SIR = 1.6, CI = 1.2-2.1), ovarian cancer(SIR = 2.3, CI = 1.7-3.0), and thyroid cancer (SIR = 2.5, CI = 1.2-4.6). Our results confirm the findings of several cohort studies carried out in Europe, the United States, and Japan, indicating that breast cancer patients should be monitored carefully for the occurrence of second primary cancers. 相似文献
30.